 |
 |
Good Morning All, With all the hype on stem cells these days, we tend to overlook these extremely important studies ONGOING NOW... Ray Strand's PMID postings reminded me to revisit this one... I'e had my "ear to the rail" on this since some time in '97 when it was first posted to PIEN by janet & followed in '98 / '99 by Judith... SEARCH PARKINSN spheramine 33 matches. Joe Bruman covered it in his CSR Retina, dopamine cells Neur 1999;52:541-546 Mar 99 http://www.geocities.com/joebruman/csr/csrindex.html Titan Pharmaceuticals' (TTP) Parkinson's Disease Cell Therapy Efficacious In Expanded Primate Studies Titan Pharmaceuticals, Inc. (AMEX: TTP - news) today announced positive efficacy results with Spheramine(TM), the Company's cell-based product, in expanded studies using a validated primate model of Parkinson's disease. Results of a three month interim analysis of the blinded, controlled study were presented today at the XIII International Congress on Parkinson's Disease in Vancouver, B.C. The studies were performed by medical scientists at Emory University, including Dr. T. Subramanian, Neurologist; Dr. Ray L. Watts, Vice Chairman of Neurology; and Dr. Roy A.E. Bakay, Vice Chairman of Neurosurgery. (press release expired) (7/29/99) October 27-28, 1999 Spheramine: A Unique Cell Therapy for Parkinson's Disease "Titan plans to initiate Phase I/II clinical trials with Spheramine late in 1999." http://www.techvestllc.com/conference/abstracts/Titan_abstract.htm Cell Implants For Parkinson's Are Ready For Human Tests http://www.personalmd.com/news/n1103093923.shtml Clinical Development for Spheramine (Phase I/II) http://www.biospace.com/ct/results.cfm?Tradename=Spheramine Titan Pharmaceuticals Inc. Spheramine: Related Articles http://www.titanpharm.com/articles/article/spheramine.html Grants for Cell Implantation Research Principal Investigator: Allen, Richard C Grant Number: 4R44NS39211-02 Title: Spheramine: a cell-based therapy for Parkinson's disease http://www.ninds.nih.gov/parkinsonsweb/grants_cell_implantation_2000.htm Titan Completes Enrollment of First Cohort of Patients In Clinical Testing of Spheramine(R) for Parkinson's Disease http://www.disabilitytimes.com/text/2001/01/26/newswire/titan1 E-MOVE reports from the 53rd Annual Meeting of the American Academy of Neurology in Philadelphia May 5-11, 2001 1. P04.102 Stereotaxic implantation of retinal pigment epithelial cells http://www.parkinson.org/implantation.htm Tuesday July 31, 7:31 am Eastern Time - Press Release Titan Pharmaceuticals, Inc. Reports Additional Positive Results From Clinical Study of Spheramine in the Treatment of Parkinson's Disease http://biz.yahoo.com/bw/010731/2093.html Titan Pharmaceuticals - Clinical Studies - Spheramine http://www.titanpharm.com/clinical_studies/spheramine_study.html Only 6 out of who knows how many... (million and a half?) But it's a very encouraging start.... Cheers ....... murray ---------------------------------------------------------------------- To sign-off Parkinsn send a message to: mailto:[log in to unmask] In the body of the message put: signoff parkinsn